Fundraising Fox

Kabeer Aziz

Investor

Partner at Adjuvant Capital

New York, New York

Writes $100K – $5M checks Β· typically $1.5M

About

Kabeer Aziz is co-founder and partner at Adjuvant Capital. He previously worked at the Global Health Investment Fund, where he managed investments including Themis, Univercells, Atomo Diagnostics, and Access Bio, and earlier held roles at Metalmark Capital investing in healthcare and at Greenhill & Co. advising on biopharmaceutical M&A. He holds a degree from the Stern School of Business at New York University.

LinkedIn β†—X / Twitter β†—
Latest on 𝕏

kabeer aziz @kadjuvant

MEDVEDEV

Sep 12, 2021

kabeer aziz @kadjuvant

β€œhe needs to get his family to the airport. he needs two more days” an epic humanitarian failure. devastating. https://t.co/pWmnVnKQBD

Aug 15, 2021 Β· β™₯ 2

kabeer aziz @kadjuvant

as @PeterKolchinsky once said, "rabies is a devil," and we couldn't agree more. excited to join @OrbiMed Oceanpine @FPrimeCapital @HillhouseCap @msacapital, and others, supporting YishengBio to scale-up rabies PEP and develop other essential vaccines https://t.co/iFekCQCJ0P

Feb 25, 2021 Β· β™₯ 5 Β· ⇄ 2

Invests in

BiotechHealthtech

Experience

  1. Adjuvant CapitalPartnercurrent2018 β€” presentNew York, NY
  2. AN2 TherapeuticsDirectorcurrent2019 β€” presentCalifornia, United States
  3. Minervax ApSDirectorcurrent2020 β€” presentDenmark
  4. PulmocideDirectorcurrent2021 β€” presentUnited Kingdom
  5. Curevo VaccineBoard Observercurrent2022 β€” presentWashington, United States
  6. Frontier Nutrition, Inc.Director2020 β€” 2026Bangladesh
  7. ChromaCode, Inc.Director2024 β€” 2026California, United States
  8. LimmaTech Biologics AGDirector2023 β€” 2024Switzerland
  9. Quantoom BiosciencesDirector2021 β€” 2023Belgium
  10. Themis Bioscience GmbHBoard Observer2018 β€” 2020Austria
  11. Global Health Investment FundSenior Associate2015 β€” 2018New York, NY
  12. Metalmark CapitalAssociate2013 β€” 2015New York, NY
  13. Greenhill & Co.Analyst2010 β€” 2013New York, NY

Education

  1. NYU Stern School of BusinessB.S., Finance & Economics

Same school

Also attended NYU Stern School of Business367

Luna SchmidInvestor at GV (Google Ventures)Kaz TeradaVenture Advisor at Monta Vista CapitalNeil FongManaging Director Asia at Burda Principal InvestmentsAlex TosoliniAdvisor at CincyTechMax WechterSenior Director of AI at Lerer HippeauTom MonahanFormer Chairman & CEO, CEB at MissionOG

+ 361 more

Shared employers

Also worked at LimmaTech Biologics AG3

Niresh BerinpanathanPrincipal at Nextech InvestVeronica Gambillara FonckPartner at Pureos BioventuresArjun BalajiInvestment Associate at Tenmile

Also worked at Global Health Investment Fund2

Glenn RockmanCo-Founder and Partner at Adjuvant CapitalWilliam GreeneVenture Partner at MPM Capital

Also worked at Metalmark Capital1

Brian PetersonInvestor at Silversmith Capital Partners

Also worked at Greenhill & Co.38

Christian TeichmannCEO & Managing Director at Burda Principal InvestmentsEmma WarleyClient Team Member at Generation Investment ManagementSteve BrotmanManaging Partner, Founder at Alpha PartnersChris ShanahanPrincipal at DFJKate CoffeyInvestment Manager at AirTree VenturesBrian SmithPartner, CFO and COO at Multicoin Capital

+ 32 more

Investments

Led

Access BioAtomo DiagnosticsThemisUnivercells

Board seats

AN2 TherapeuticsMinervaXUnivercells VaccinesYisheng Biopharma

Per the firm's website.

Colleagues at Adjuvant Capital

Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
David Washer
Investor at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital

Network1

Glenn Rockman
Co-Founder and Partner at Adjuvant Capital

Investors connected to Kabeer in public investor directories β€” a warm-intro map.